Shares of ESPR are trading 5% higher today. Here's why:

 Esperion Theraptc (ESPR) is trading 5% higher at $7.795 today. The stock's price action is strongly outpacing it's peers on what is quickly becoming a somewhat glum day for the Health Care sector.

The stock is likely continuing to move on recent positive news from the last few weeks:

- New York State Common Retirement Fund has bought 4,500 shares of Esperion Therapeutics (NASDAQ:ESPR).
- Esperion Therapeutics had a mixed second quarter, with positive update on CLEAR Outcomes Trial offsetting earnings.
- Jefferies Financial Group Equities Analysts have raised their earnings estimates for Esperion Therapeutics (NASDAQ:ESPR).
- U.S. net product revenue of cholesterol lowering therapies Nexletol and Nexlizet grew 28% year-over-year to $13.58 million in the second quarter of 2020.